Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved clinical biomarkers and companion biomarker diagnostics (e.g., point of care and/or direct-to-consumer tests, DTC) to support the clinical development


of non-hormonal contraceptive product(s) for men and women.
Related Programs

Child Health and Human Development Extramural Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: $100,000,000


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-22-018.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-22-018.html

Contact:


Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:


Date Posted:
2021-04-15

Application Due Date:


Archive Date:
2021-09-03


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.






More Federal Domestic Assistance Programs


Food for Peace Development Assistance Program (DAP) | Veterans" Employment Program | Centers for Independent Living, Recovery Act. | Marine Corps Systems Command Federal Assistance Program | Native American Housing Block Grants (Formula) Recovery Act Funded |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders